Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pfizer explores options for some rare disease and cancer drugs
The US drugmaker said these options included collaborations with other drug developers for these medicines, or establishing a new…
Novavax’s CEO Stanley Erck to retire this month
Erck, who has been at the helm of the company since 2011, was responsible for bringing Novavax's COVID vaccine, its first…
Teva says opioids settlement to move forward in US
Teva said recently it has either already settled with or confirmed participation from 48 of the 50 states, and will continue to…
Indegene expands European presence with new centre in Germany
With this centre, Indegene is further strengthening its presence in Europe to help lifesciences companies fast-track digital…
BioAsia 2023 announces speaker line-up
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations and academia,…
USFDA approves Prasugrel tablets by Lupin
The product will be manufactured at Lupin’s facility in Goa
USFDA approves Febuxostat tablets by Zydus
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Glenmark Pharma launches Bumetanide injection vials
According to IQVIA sales data for the 12-month period ending November 2022, the Bumex injection, 0.25 mg/mL market achieved annual…
Lupin and Exeltis announce reimbursement approval of NaMuscla
Agreement enables sustainable patient access of the only EU-approved treatment for myotonia symptoms
There is a high-quality talent pool in the specialist area of pharma engineering design in India
With over 55 per cent of the Dublin-based PM Group's business coming from the pharma sector, Anandhi Sathyamurthy, MD-India, PM…